NM_052867.4:c.644+6168A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052867.4(NALCN):​c.644+6168A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 152,118 control chromosomes in the GnomAD database, including 2,964 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 2964 hom., cov: 33)

Consequence

NALCN
NM_052867.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0180

Publications

0 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.38 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.644+6168A>G intron_variant Intron 6 of 43 ENST00000251127.11 NP_443099.1 Q8IZF0-1A0A024RE05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.644+6168A>G intron_variant Intron 6 of 43 1 NM_052867.4 ENSP00000251127.6 Q8IZF0-1

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
28657
AN:
152000
Hom.:
2957
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.242
Gnomad EAS
AF:
0.393
Gnomad SAS
AF:
0.279
Gnomad FIN
AF:
0.274
Gnomad MID
AF:
0.178
Gnomad NFE
AF:
0.189
Gnomad OTH
AF:
0.187
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.189
AC:
28678
AN:
152118
Hom.:
2964
Cov.:
33
AF XY:
0.197
AC XY:
14642
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.122
AC:
5056
AN:
41502
American (AMR)
AF:
0.194
AC:
2960
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.242
AC:
839
AN:
3468
East Asian (EAS)
AF:
0.394
AC:
2031
AN:
5150
South Asian (SAS)
AF:
0.279
AC:
1348
AN:
4830
European-Finnish (FIN)
AF:
0.274
AC:
2893
AN:
10566
Middle Eastern (MID)
AF:
0.164
AC:
48
AN:
292
European-Non Finnish (NFE)
AF:
0.189
AC:
12822
AN:
68000
Other (OTH)
AF:
0.188
AC:
396
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1179
2359
3538
4718
5897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
2674
Bravo
AF:
0.182
Asia WGS
AF:
0.357
AC:
1241
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.3
DANN
Benign
0.51
PhyloP100
0.018
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3918319; hg19: chr13-102022883; API